Liquidity and Capital Risk Webinar Set for July 20

COLLEGE PARK, Md. – June 30, 2022 – The Center for Financial Policy at the University of Maryland’s Robert H. Smith School of Business, and Deloitte, will present a Liquidity and Capital Risk Webinar for financial professionals, from 9-10 a.m. Wednesday, July 20, 2022.

Mitigating Drug Shortages via a Quality Management Rating System is Viable: New Study

The longstanding ‘safe and effective’ regulatory approach to assure Americans their drug products meet a high standard of quality remains effective. However, the pharmaceutical industry needs an additional apparatus – a quality rating system – to address recent supply shortages that are attributable to deficiencies in manufacturing practices, says Maryland Smith’s Clifford Rossi, a risk management expert. Think CMNS nursing home ratings and CARFAX® car history reports, he adds.

Climate Finance Risk Management Virtual Bootcamp Dovetails with SEC Proposed Disclosure Rules

The Securities and Exchange Commission’s recently proposed updated rules for public companies to report the climate-related impact of their businesses to the federal government and their shareholders. While the commission collects public comments on the proposal up to June 17, the University of Maryland has crafted a Climate Finance and Risk Management Bootcamp (June 23 and 30) geared to mid-career and senior professionals across industries, who increasingly weigh climate-change factors into business decisions and financial disclosures.

UMD to Present Climate Finance and Risk Management Bootcamp

As climate change increasingly affects business decision-making, risk managers, financial analysts and other leaders must anticipate how weather events may impact their growth outlook, estimate how port taxes may increase because of rising sea levels, develop contingencies for supply chain disruptions and respond to the unexpected.

Maryland Smith’s Rossi Selected for FDA Committee

Maryland Smith finance professor Clifford Rossi has been selected by the Food and Drug Administration to serve on its Pharmaceutical Science and Clinical Pharmacology Advisory Committee.

The Art and Science of Risk Management

Beyond quantifying and getting their boards to understand traditional financial risks such as credit and market risk, corporate risk officers are grappling with a host of nontraditional risks associated with and ranging from cyber to ESG (environmental, social and governance) and DEI (diversity, equity and inclusion).

Finance Themes to Watch for During COP26

As global leaders and business leaders convene in Glasgow for the 26th UN Climate Change Conference of the Parties (COP26), Maryland Smith’s Clifford Rossi will be watching the headlines.

New Study Shows Path to Uninterrupted Supply of Safe, Effective Drugs for US Consumers

A combination of factors including the current corporate tax rate makes pharmaceutical production in the United States more attractive now than investing in either China or India. And adopting advanced technologies such as Continuous Manufacturing (CM) further positions the United States to recapture a prominent position in pharmaceutical manufacturing.

New ‘Federal Risk Academy’ Certificate Program to Launch from Maryland Smith’s Center for Financial Policy

The Center for Financial Policy (CFP) at the University of Maryland’s Robert H. Smith School of Business and Deloitte have jointly developed a new risk management training program they will deliver to government financial professionals beginning on Jan. 11, 2022. The certificate program, called the Maryland Smith Federal Risk Academy, will provide thought leadership, training, and special events to federal employees engaged in credit, banking, loans, grants, insurance and other market activities.

Is It Time for Financial Climate Risk Regulation?

Financial institutions should be accounting for climate change, but risk models currently are insufficient for regulators to mandate climate stress testing or capital requirements, Maryland Smith’s Clifford Rossi said this week, speaking to the Subcommittee on Consumer Protection and Financial Institutions in the U.S. House of Representatives.

Back to Top